Aug 4 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2016 Jun 30, 2015 Dec 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 44 mln 7 mln 188 mln
(+464.9 pct) (+88.2 pct) (+55.5 pct)
Operating loss 410 mln loss 505 mln loss 1.27
Recurring loss 416 mln loss 405 mln loss 1.27
Net loss 417 mln loss 406 mln loss 1.28
EPS loss 45.51 yen loss 44.26 yen loss 138.94 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T
((Tokyo Headline News Desk +813 6441 1812))